share_log

康希諾生物:2023年股東週年大會通函

CANSINOBIO: 2023 AGM CIRCULAR

HKEX ·  Jun 4 16:37
Summary by Futu AI
康希諾生物股份公司將於2024年6月27日在天津東凱悅酒店召開2023年股東週年大會,討論包括選舉第三屆董事會非執行董事、審核2023年董事會及監事會報告、年報及財務決算報告、利潤分配方案等14項議案。此外,將提出修訂未來三年(2023-2025年)股東分紅回報規劃、發行A股及╱或H股的一般授權、以簡易程序發行A股的一般授權、回購A股及╱或H股的一般授權以及授權發行境內外債務融資工具等事項。會議通知已於公司網站及香港聯交所網站公布,並附有相應的代表委任表格。股東若欲委任代表出席大會,須於會議召開前24小時提交代表委任表格。
康希諾生物股份公司將於2024年6月27日在天津東凱悅酒店召開2023年股東週年大會,討論包括選舉第三屆董事會非執行董事、審核2023年董事會及監事會報告、年報及財務決算報告、利潤分配方案等14項議案。此外,將提出修訂未來三年(2023-2025年)股東分紅回報規劃、發行A股及╱或H股的一般授權、以簡易程序發行A股的一般授權、回購A股及╱或H股的一般授權以及授權發行境內外債務融資工具等事項。會議通知已於公司網站及香港聯交所網站公布,並附有相應的代表委任表格。股東若欲委任代表出席大會,須於會議召開前24小時提交代表委任表格。
Cansinobio will hold the 2023 shareholder annual meeting on June 27, 2024 at the Hyatt Hotel in Tianjin, where 14 proposals are to be discussed, including the election of non-executive directors for the third board of directors, review of the 2023 board of directors and supervisory committee reports, annual reports and financial statements, profit distribution plans, etc. In addition, proposals will be made for amending the shareholder dividend return plan for the next three years (2023-2025), general authorization for issuance of A-shares and/or H-shares, general authorization for issuance of A-shares through simplified procedures, general authorization for repurchase of A-shares and/or H-shares, and authorization for issuance of domestic and foreign debt financing tools. The meeting notice has been posted on the company's website and the Hong Kong Stock Exchange website, along with corresponding representative appointment forms. Shareholders who wish to appoint representatives to attend the meeting must submit the representative appointment form 24 hours before the meeting.
Cansinobio will hold the 2023 shareholder annual meeting on June 27, 2024 at the Hyatt Hotel in Tianjin, where 14 proposals are to be discussed, including the election of non-executive directors for the third board of directors, review of the 2023 board of directors and supervisory committee reports, annual reports and financial statements, profit distribution plans, etc. In addition, proposals will be made for amending the shareholder dividend return plan for the next three years (2023-2025), general authorization for issuance of A-shares and/or H-shares, general authorization for issuance of A-shares through simplified procedures, general authorization for repurchase of A-shares and/or H-shares, and authorization for issuance of domestic and foreign debt financing tools. The meeting notice has been posted on the company's website and the Hong Kong Stock Exchange website, along with corresponding representative appointment forms. Shareholders who wish to appoint representatives to attend the meeting must submit the representative appointment form 24 hours before the meeting.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.